What We're Reading: Page 11
Industry reads hand-picked by our editors
Oct 14, 2025
-
The Wall Street Journal
Why Biotech’s Rally Can Last This Time
-
MIT Technology Review
How aging clocks can help us understand why we age—and if we can reverse it
-
Healthcare Dive
Trump administration moves to fire HHS employees amid shutdown
-
The Financial Times
Mirador fundraising raises hopes of revival in US biotech market
Oct 10, 2025
-
The Washington Post
She left the medical mainstream and rose to be RFK Jr.’s surgeon general pick
-
Endpoints News
In China, a low-cost push to rival a life-saving, $2M medicine
-
Nature
Cancer cachexia contender enters first pivotal trial
-
Bloomberg
Europe Risks Losing Drug Access in Trump Plan, Ex-Novo CEO Warns
Oct 09, 2025
Oct 08, 2025
Oct 07, 2025
Oct 06, 2025
Oct 03, 2025
-
Nature
AI has designed thousands of potential antibiotics. Will any work?
-
Bloomberg
Alnylam Pulls TV Ad After Trump Crackdown on Drug Industry Spots
-
Endpoints News
Biotech IPOs in Hong Kong far outpace the US driven by China’s buzzy biotech sector
-
NPR
The CDC still hasn’t issued COVID vaccine guidelines, leaving access in limbo
Previous
